Meeting Coverage
ISC
International Stroke Conference
SELECT2 trial's 1-year results show continued benefits for patients with slower recovery
Latest ISC Meeting Coverage
Landmark trials establish a new standard of care, experts say
Large observational study might not deliver definitive answers but hints at a better strategy
Lytic at least appeared safe in a selected population with many undergoing thrombectomy
Trial from China shows potential of AI guidance for stroke care
TREND trial compares acute antiplatelet monotherapies
Small single-center trial suggests time delays will be a critical hurdle
Pooled trial analysis finally provides the evidence for combination approach
Phase III trial is the "disappointing end of a long journey"
MARVEL trial tries adjunctive therapy again with new circumstances but gets the same old answer
Tilting the head of the bed up during early window in large vessel occlusion hurts outcomes
DAPT turns in non-inferior results versus IV alteplase in ARAMIS trial from China
Chinese trial supports stronger antiplatelet for patients ineligible for lytics, thrombectomy
Among six interventions, uric acid exceeded efficacy boundaries
Pair of phase III trials lay the groundwork for expanding indication